HERC5 Antikörper (AA 153-284) (Biotin)

Produktnummer ABIN7150947

Der Kaninchen Polyklonal Anti-HERC5-Antikörper wurde für ELISA validiert. Er ist geeignet, HERC5 in Proben von Human zu detektieren.

Kurzübersicht für HERC5 Antikörper (AA 153-284) (Biotin) (ABIN7150947)

Target: HERC5 (Hect Domain and RLD 5 (HERC5))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser HERC5 Antikörper ist konjugiert mit Biotin

Applikation: ELISA

Produktdetails anti-HERC5 Antikörper (Biotin)

Bindungsspezifität: AA 153-284

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human E3 ISG15--protein ligase HERC5 protein (153-284AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu HERC5

Target: HERC5 (Hect Domain and RLD 5 (HERC5))

Andere Bezeichnung: HERC5

Hintergrund:

Background: Major E3 ligase for ISG15 conjugation. Acts as a positive regulator of innate antiviral response in cells induced by interferon. Functions as part of the ISGylation machinery that recognizes target proteins in a broad and relatively non-specific manner. Catalyzes ISGylation of IRF3 which results in sustained activation, it attenuates IRF3-PIN1 interaction, which antagonizes IRF3 ubiquitination and degradation, and boosts the antiviral response. Catalyzes ISGylation of influenza A viral NS1 which attenuates virulence, ISGylated NS1 fails to form homodimers and thus to interact with its RNA targets. Catalyzes ISGylation of papillomavirus type 16 L1 protein which results in dominant-negative effect on virus infectivity. Physically associated with polyribosomes, broadly modifies newly synthesized proteins in a cotranslational manner. In an interferon-stimulated cell, newly translated viral proteins are primary targets of ISG15.

Aliases: CEB1 antibody, CEBP1 antibody, Cyclin E binding protein 1 antibody, Cyclin-E-binding protein 1 antibody, E3 ISG15--protein ligase HERC5 antibody, HECT domain and RCC1 like domain containing protein 5 antibody, HECT domain and RCC1-like domain-containing protein 5 antibody, Hect domain and RLD 5 antibody, HECT E3 ubiquitin ligase antibody, HERC5 antibody, HERC5_HUMAN antibody, Herc6 antibody

UniProt: Q9UII4